EP2809336
FACTOR XII INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL INFLAMMATORY DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.1.2013EP published:
20.6.2018EP application number:
13701651.5
EPO information:
European Patent Register
Max expiry date:
30.1.2033
Title:
FACTOR XII INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL INFLAMMATORY DISORDERS
Timeline
Today
31.1.2013EP application
20.6.2018EP Publication
Owner
Name:
CSL Behring GmbHAddress:
Emil-von-Behring-Strasse 76, 35041, Marburg, DE
Name:
CSL LimitedAddress:
45 Poplar Road, 3052, Parkville VIC, AU
Name:
Julius-Maximilians-Universitaet WuerzburgAddress:
Sanderring 2, 97070, Wuerzburg, DE
Name:
Westfälische Wilhelms-Universität MünsterAddress:
Schlossplatz 2, 48149, Münster, DE
Inventor
Name:
MEUTH, SvenAddress:
Muenster, DE
Name:
GOEBEL, KerstinAddress:
Pfaffenhausen, DE
Name:
KLEINSCHNITZ, ChristophAddress:
Heiligenhaus-Isenbuegel, DE
Name:
MCKENZIE, BrentAddress:
San MateoCA, US
Name:
NOLTE, MarcAddress:
Marburg, DE
Priority
Number:
12153341Date:
31.1.2012Country:
EP
Number:
201261592652 PDate:
31.1.2012Country:
US
Classification
Categories:
A61K 38/06, A61K 38/48, A61K 38/55, A61K 38/57, A61K 39/395, A61K 47/50, C07K 14/81, C07K 16/36, C07K 16/40, A61P 25/00, A61P 37/00, A61K 38/17